Delivery Order SPE2DB20D3103-SPE2DB25FN8P2
Award Date
5/16/25
Potential Completion Date
5/19/25
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The firm-fixed-price delivery order, valued at $15,684.96, has an ultimate completion date of December 4, 2024. The contract does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite...
This federal contract award, valued at $2,620.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty medication. It is a firm fixed-price delivery order contract with a completion date of January 17, 2023. The contract was not set aside for any specific business category. Amerisourcebergen holds a $999,999,999...
This federal contract award, valued at $3,052.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a medical product, with a period of performance through March 2025. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
The Defense Logistics Agency (DLA) awarded a $3,615.28 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for the provision of AIMOVIG 70 MG/ML AUTOINJECTORML. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $26,227.61 delivery order contract is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a prescription medication. The contract is a firm-fixed price, non-set-aside award with a performance period through May 8, 2025. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is a delivery order valued at $7,010.94 awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, with a period of performance through November 1, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $10,026.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a medication, with a completion date of December 23, 2024. The contract type is Firm Fixed Price. This award is not associated with a set-aside program and is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order worth $10,844.44 for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 3, 2025. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $3,052.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order under an Indefinite Delivery Contract (IDC), is for the provision of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty medication. The contract has a period of performance through January 31, 2025 and uses a Firm Fixed Price pricing type. This award is not designated as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,112.89 firm fixed-price delivery order is for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract has an ultimate completion date of February 13, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...